These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12198043)

  • 1. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
    De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
    Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
    De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
    Anesthesiology; 2003 Jan; 98(1):133-42. PubMed ID: 12502989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis: a study in a rat model.
    De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
    Eur J Anaesthesiol; 2005 Aug; 22(8):591-6. PubMed ID: 16119595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
    Dragne A; Varin F; Plaud B; Donati F
    Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of rocuronium at the vocal cords and the adductor pollicis in humans.
    Plaud B; Proost JH; Wierda JM; Barre J; Debaene B; Meistelman C
    Clin Pharmacol Ther; 1995 Aug; 58(2):185-91. PubMed ID: 7648768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
    van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure.
    Robertson EN; Driessen JJ; Booij LH
    Eur J Anaesthesiol; 2005 Jan; 22(1):4-10. PubMed ID: 15816565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.
    Wierda JM; Meretoja OA; Taivainen T; Proost JH
    Br J Anaesth; 1997 Jun; 78(6):690-5. PubMed ID: 9215021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rocuronium in two myasthenic patients undergoing thymectomy.
    Sanfilippo M; Fierro G; Cavalletti MV; Biancari F; Vilardi V
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1365-6. PubMed ID: 9422307
    [No Abstract]   [Full Text] [Related]  

  • 12. Rocuronium in the myasthenic patient.
    Baraka A; Haroun-Bizri S; Kawas N; Hajjar AM; Kawkabani N
    Anaesthesia; 1995 Nov; 50(11):1007. PubMed ID: 8678231
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.
    McCoy EP; Mirakhur RK; Maddineni VR; Wierda JM; Proost JH
    Br J Anaesth; 1996 Jan; 76(1):29-33. PubMed ID: 8672375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target controlled infusion of rocuronium: analysis of effect data to select a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V
    Br J Anaesth; 2003 Feb; 90(2):183-8. PubMed ID: 12538375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and late reversibility of rocuronium bromide.
    van den Broek L; Proost JH; Wierda JM
    Eur J Anaesthesiol Suppl; 1994; 9():128-32. PubMed ID: 7925203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients].
    Suzuki T; Saeki S; Takeda J; Ozaki M; Iwao Y
    Masui; 2006 Apr; 55(4):419-27. PubMed ID: 16634542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisatracurium in a myasthenic patient undergoing thymectomy.
    Baraka A; Siddik S; Kawkabani N
    Can J Anaesth; 1999 Aug; 46(8):779-82. PubMed ID: 10451139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an intubating dose of succinylcholine and rocuronium on the larynx and diaphragm: an electromyographic study in humans.
    Dhonneur G; Kirov K; Slavov V; Duvaldestin P
    Anesthesiology; 1999 Apr; 90(4):951-5. PubMed ID: 10201662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia.
    Lowry DW; Mirakhur RK; McCarthy GJ; Carroll MT; McCourt KC
    Anesth Analg; 1998 Oct; 87(4):936-40. PubMed ID: 9768798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.